BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27322408)

  • 1. True Effects or Bias? MMP-2 and MMP-9 Serum Concentrations after Acute Stroke.
    Kreisel SH; Stroick M; Griebe M; Alonso A; Reuter B; Hennerici MG; Fatar M
    Cerebrovasc Dis; 2016; 42(5-6):352-360. PubMed ID: 27322408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase expression after human cardioembolic stroke: temporal profile and relation to neurological impairment.
    Montaner J; Alvarez-Sabín J; Molina C; Anglés A; Abilleira S; Arenillas J; González MA; Monasterio J
    Stroke; 2001 Aug; 32(8):1759-66. PubMed ID: 11486102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum matrix metalloproteinase-8, tissue inhibitor of metalloproteinase and myeloperoxidase in ischemic stroke.
    Palm F; Pussinen PJ; Safer A; Tervahartiala T; Sorsa T; Urbanek C; Becher H; Grau AJ
    Atherosclerosis; 2018 Apr; 271():9-14. PubMed ID: 29453088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MMP-2 concentrations in stroke according to etiology: adjusting for enzyme degradation in stored deep-frozen serum and other methodological pitfalls.
    Kreisel SH; Stroick M; Reuter B; Senn E; Hennerici MG; Fatar M
    J Clin Neurosci; 2012 Nov; 19(11):1564-7. PubMed ID: 22959677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke.
    Montaner J; Alvarez-Sabín J; Molina CA; Anglés A; Abilleira S; Arenillas J; Monasterio J
    Stroke; 2001 Dec; 32(12):2762-7. PubMed ID: 11739970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of edaravone, a free radical scavenger, on serum levels of inflammatory biomarkers in acute brain infarction.
    Isahaya K; Yamada K; Yamatoku M; Sakurai K; Takaishi S; Kato B; Hirayama T; Hasegawa Y
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):102-7. PubMed ID: 21215657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases and their inhibitors in different acute stroke subtypes.
    Vukasovic I; Tesija-Kuna A; Topic E; Supanc V; Demarin V; Petrovcic M
    Clin Chem Lab Med; 2006; 44(4):428-34. PubMed ID: 16599837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Matrix Metalloproteinase-9 and Cognitive Impairment After Acute Ischemic Stroke.
    Zhong C; Bu X; Xu T; Guo L; Wang X; Zhang J; Cui Y; Li D; Zhang J; Ju Z; Chen CS; Chen J; Zhang Y; He J
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29306898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Accuracy of Serum Matrix Metalloproteinase-9 for Predicting Hemorrhagic Transformation After Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Wang L; Wei C; Deng L; Wang Z; Song M; Xiong Y; Liu M
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1653-1665. PubMed ID: 29598905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Matrix Metalloproteinase-9 Is Associated With Depression After Acute Ischemic Stroke.
    Che B; Zhong C; Ge J; Li R; Zhu Z; Bu X; Xu T; Ju Z; Liu J; Zhang J; Chen J; Zhang Y; He J
    Circ J; 2019 Oct; 83(11):2303-2311. PubMed ID: 31564697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix Metalloproteinase-9 and Recovery of Acute Ischemic Stroke.
    Abdelnaseer MM; Elfauomy NM; Esmail EH; Kamal MM; Elsawy EH
    J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):733-740. PubMed ID: 28063771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.
    Castellanos M; Sobrino T; Millán M; García M; Arenillas J; Nombela F; Brea D; Perez de la Ossa N; Serena J; Vivancos J; Castillo J; Dávalos A
    Stroke; 2007 Jun; 38(6):1855-9. PubMed ID: 17478737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies.
    Horstmann S; Kalb P; Koziol J; Gardner H; Wagner S
    Stroke; 2003 Sep; 34(9):2165-70. PubMed ID: 12907822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-9 contributes to the increase of tau protein in serum during acute ischemic stroke.
    Kurzepa J; Bielewicz J; Grabarska A; Stelmasiak Z; Stryjecka-Zimmer M; Bartosik-Psujek H
    J Clin Neurosci; 2010 Aug; 17(8):997-9. PubMed ID: 20627731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum matrix metalloproteinase-9 levels and prognosis of acute ischemic stroke.
    Zhong C; Yang J; Xu T; Xu T; Peng Y; Wang A; Wang J; Peng H; Li Q; Ju Z; Geng D; Zhang Y; He J;
    Neurology; 2017 Aug; 89(8):805-812. PubMed ID: 28747453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasma matrix metalloproteinase-9 levels in patients with acute ischemic stroke.
    Cojocarui IM; Cojocaru M; Sapira V; Socoliuc G; Hertea C; Paveliu S
    Rom J Intern Med; 2012; 50(2):155-8. PubMed ID: 23326959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke.
    Lucivero V; Prontera M; Mezzapesa DM; Petruzzellis M; Sancilio M; Tinelli A; Di Noia D; Ruggieri M; Federico F
    Neurol Sci; 2007 Aug; 28(4):165-70. PubMed ID: 17690845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-arterial bone marrow mononuclear cell transplantation correlates with GM-CSF, PDGF-BB, and MMP-2 serum levels in stroke patients: results from a clinical trial.
    Moniche F; Montaner J; Gonzalez-Marcos JR; Carmona M; Piñero P; Espigado I; Cayuela A; Escudero I; de la Torre-Laviana FJ; Boada C; Rosell A; Mayol A; Jimenez MD; Gil-Peralta A; Gonzalez A
    Cell Transplant; 2014; 23 Suppl 1():S57-64. PubMed ID: 25335778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-nucleotide polymorphisms of MMP-2 gene in stroke subtypes.
    Fatar M; Stroick M; Steffens M; Senn E; Reuter B; Bukow S; Griebe M; Alonso A; Lichtner P; Bugert P; Meitinger T; Wienker TF; Hennerici MG
    Cerebrovasc Dis; 2008; 26(2):113-9. PubMed ID: 18560213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased plasma decorin levels following acute ischemic stroke: correlation with MMP-2 and differential expression in TOAST subtypes.
    Xu YZ; Zhao KJ; Yang ZG; Zhang YH; Zhang YW; Hong B; Liu JM
    Mol Med Rep; 2012 Dec; 6(6):1319-24. PubMed ID: 23026977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.